(Q74408895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M J Cantwell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W G Wierda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I S Lossos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Levy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T J Kipps

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1451-1457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516107%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402208

10 November 2019

exact match

0 references

cites work

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Functions of CD40 and its ligand, gp39 (CD40L).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

An improved anion-exchange HPLC method for the detection and purification of adenoviral particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Use of recombinant adenovirus for metabolic engineering of mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402208

7 January 2021